SI-BONE, INC. Operating Cash Flow
SI-BONE, INC. (SIBN) reported Operating Cash Flow of -$1.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- SI-BONE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $777.00K, a 349.13% increase year-over-year.
- SI-BONE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.36M.
- SI-BONE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $1.73M, a 46.69% increase year-over-year.
- SI-BONE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $2.33M, a 673.18% increase year-over-year.
- SI-BONE, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$675.00K.
- SI-BONE, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$12.43M.
- SI-BONE, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$18.71M.
- SI-BONE, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$41.66M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $777.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.58M 10-Q · filed 2026-08-04 | $143.00K derived: sum of 3 quarters · filed 2026-08-04 | $2.48M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$2.36M 10-Q · filed 2026-05-11 | -$634.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.70M derived: sum of 3 quarters · filed 2026-05-11 | $1.87M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.06M derived: sum of 2 quarters · filed 2026-02-24 | $4.24M derived: sum of 3 quarters · filed 2026-08-04 | -$675.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.51M derived: sum of 2 quarters · filed 2026-08-04 | -$2.40M 10-Q · filed 2025-11-10 | -$1.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$4.74M 10-Q · filed 2026-08-04 | -$3.56M derived: sum of 3 quarters · filed 2026-08-04 | -$3.26M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$4.91M 10-Q · filed 2026-05-11 | -$3.73M derived: sum of 2 quarters · filed 2026-05-11 | -$3.43M derived: sum of 3 quarters · filed 2026-05-11 | -$9.77M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.48M derived: sum of 2 quarters · filed 2026-02-24 | -$4.85M derived: sum of 3 quarters · filed 2026-02-24 | -$12.43M 10-K · filed 2026-02-24 |
| 2024-09-30 | $302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$6.03M derived: sum of 2 quarters · filed 2025-11-10 | -$13.60M 10-Q · filed 2025-11-10 | -$15.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$6.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$13.90M 10-Q · filed 2025-08-05 | -$16.20M derived: sum of 3 quarters · filed 2026-02-24 | -$18.27M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$7.57M 10-Q · filed 2025-05-06 | -$9.87M derived: sum of 2 quarters · filed 2026-02-24 | -$11.94M derived: sum of 3 quarters · filed 2026-02-24 | -$15.53M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$4.37M derived: sum of 2 quarters · filed 2026-02-24 | -$7.96M derived: sum of 3 quarters · filed 2026-02-24 | -$18.71M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.66M derived: sum of 2 quarters · filed 2024-11-12 | -$16.42M 10-Q · filed 2024-11-12 | -$23.19M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$14.34M 10-Q · filed 2024-08-06 | -$21.12M derived: sum of 3 quarters · filed 2025-02-25 | -$27.64M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$10.75M 10-Q · filed 2024-05-07 | -$17.53M derived: sum of 2 quarters · filed 2025-02-25 | -$24.05M derived: sum of 3 quarters · filed 2025-02-25 | -$38.90M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$6.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$13.30M derived: sum of 2 quarters · filed 2025-02-25 | -$28.14M derived: sum of 3 quarters · filed 2025-02-25 | -$41.66M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$6.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$21.37M derived: sum of 2 quarters · filed 2023-11-07 | -$34.88M 10-Q · filed 2023-11-07 | -$47.59M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$14.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$28.35M 10-Q · filed 2023-08-08 | -$41.07M derived: sum of 3 quarters · filed 2023-08-08 | -$50.38M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$13.51M 10-Q · filed 2023-05-02 | -$26.23M derived: sum of 2 quarters · filed 2023-05-02 | -$35.53M derived: sum of 3 quarters · filed 2023-05-02 | -$43.69M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | -$12.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$22.02M derived: sum of 2 quarters · filed 2023-03-02 | -$30.17M derived: sum of 3 quarters · filed 2023-03-02 | -$39.53M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$9.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$17.46M derived: sum of 2 quarters · filed 2022-11-08 | -$26.82M 10-Q · filed 2022-11-08 | -$34.70M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$8.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$17.51M 10-Q · filed 2022-08-09 | -$25.39M derived: sum of 3 quarters · filed 2022-08-09 | -$30.94M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$9.36M 10-Q · filed 2022-05-10 | -$17.24M derived: sum of 2 quarters · filed 2022-05-10 | -$22.79M derived: sum of 3 quarters · filed 2022-05-10 | -$30.67M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$13.43M derived: sum of 2 quarters · filed 2022-03-01 | -$21.31M derived: sum of 3 quarters · filed 2022-03-01 | -$30.66M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$13.43M derived: sum of 2 quarters · filed 2021-11-09 | -$22.78M 10-Q · filed 2021-11-09 | -$31.81M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$7.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$17.23M 10-Q · filed 2021-08-04 | -$26.26M derived: sum of 3 quarters · filed 2021-08-04 | -$33.38M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$9.36M 10-Q · filed 2021-05-04 | -$18.39M derived: sum of 2 quarters · filed 2021-05-04 | -$25.51M derived: sum of 3 quarters · filed 2021-05-04 | -$33.90M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$16.15M derived: sum of 2 quarters · filed 2021-03-10 | -$24.55M derived: sum of 3 quarters · filed 2021-03-10 | -$31.63M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$15.52M derived: sum of 2 quarters · filed 2020-11-03 | -$22.59M 10-Q · filed 2020-11-03 | -$28.91M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | -$8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$15.47M 10-Q · filed 2020-08-04 | -$21.79M derived: sum of 3 quarters · filed 2020-08-04 | -$24.32M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | -$7.08M 10-Q · filed 2020-05-05 | -$13.39M derived: sum of 2 quarters · filed 2020-05-05 | -$15.92M derived: sum of 3 quarters · filed 2020-05-05 | -$17.19M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$8.85M derived: sum of 2 quarters · filed 2020-03-11 | -$10.11M derived: sum of 3 quarters · filed 2020-03-11 | -$14.52M 10-K · filed 2020-03-11 |
| 2018-09-30 | -$2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$3.79M derived: sum of 2 quarters · filed 2019-11-12 | -$8.20M 10-Q · filed 2019-11-12 | -$12.24M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$5.67M 10-Q · filed 2019-08-07 | -$9.71M derived: sum of 3 quarters · filed 2019-08-07 | |
| 2018-03-31 | -$4.41M 10-Q · filed 2019-05-09 | -$8.45M derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$17.53M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | -$13.49M 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |